The coronavirus outbreak has resulted a shortage of diagnostic tools and infrastructure, generating opportunities for players in the chemiluminescence immunoassay (CLIA) analyzer market to bridge the ...

Rising prevalence of chronic as well as acute diseases and technological advancements in CLIA analyzers are key factors driving market revenue growth. VANCOUVER, BRITISH COLUMBIA, CANADA, July 1, 2024 ...

Anbio, a leading provider of innovative diagnostic solutions, proudly presents the Anbio ADL i1910, a fully automated, compact, and affordable CLIA analyzer ...

East Windsor, New Jersey, October 2, 2007 — Abbott announced today that the U.S. Food and Drug Administration (FDA) has granted waived status under the Clinical Laboratory Improvement Amendements of ...